Logotipo del repositorio
Logotipo del repositorio
 

Biochemical Markers Present in a Population Susceptible to Suffering From Metabolic Syndrome

Vista sencilla de ítem
dc.contributor.authorDíaz-Pérez, Anderson
dc.contributor.authorRoldán Menco, Consuelo
dc.contributor.authorBarrios Puerta, Zorayda
dc.contributor.authorBadillo-Viloria, María
dc.contributor.authorNavarro-Quiroz, Elkin
dc.contributor.authorYañez Torregroza, Zuleima
dc.contributor.authorMendoza Cataño, Carmenza Leonor
dc.date.accessioned2018-03-16T16:22:47Z
dc.date.available2018-03-16T16:22:47Z
dc.date.issued2018
dc.description.abstractObjective: To determine the prevalence of metabolic syndrome (SM) according to Adult Treatment Panel III ATPIII and its relation with uric acid concentration and C-reactive protein, in people aged from 45 to 60 years old from the Getsemaní neighborhood of Cartagena city, Colombia. Materials and Methods: Type of study: Observational, Descriptive-Correlation. Population of 802 inhabitants from the Getsemaní neighborhood of Cartagena city. We analyzed 302 inhabitants from a random sample with 95% confidence level and 5% of error level. The ATP III diagnostic criteria were applied, the applied instrument had basic data about the general context (social, demographic, economic aspects, family history, work activity and its physical characteristics: weight, waist circumference, blood pressure, calculation of BMI), as well diagnostic tests as: glycaemia, total cholesterol, triglycerides, HDLc, LDLc, uric acid, ultrasensitive C-reactive protein. Results: The population susceptible to metabolic syndrome presented a prevalence of 18%. The most prevalent metabolic syndrome factor was abdominal obesity with 85%, followed by an increase in triglycerides by 76%. Conclusion: When applying the ATP III criteria, the prevalence of metabolic syndrome was considered high. There was no significant association of C-reactive protein values with the possibility of developing metabolic syndrome in both men and women, but uric acid results were found to be correlated in the group of women susceptible to MS with a p = 0.0022.eng
dc.identifier.issn19169744
dc.identifier.urihttp://hdl.handle.net/20.500.12442/1874
dc.language.isoengspa
dc.publisherCanadian Center of Science and Educationeng
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess
dc.rights.licenseLicencia de Creative Commons Reconocimiento-NoComercial-CompartirIgual 4.0 Internacionalspa
dc.sourceGlobal Journal of Health Scienceeng
dc.sourceVol. 10, No. 4 (2018)spa
dc.source.urihttps://doi.org/10.5539/gjhs.v10n4p85
dc.subjectHypertensioneng
dc.subjectUric acideng
dc.subjectObesityeng
dc.subjectRisk factorseng
dc.titleBiochemical Markers Present in a Population Susceptible to Suffering From Metabolic Syndromeeng
dc.typearticleeng
dcterms.referencesAguilar, M., Bhuket, T., Torres, S., Liu, B., & Wong, R. J. (2015). Prevalence of the metabolic syndrome in the United States, 2003-2012. Jama, 313(19), 1973-1974. https://doi.org/10.1001/jama.2015.4260eng
dcterms.referencesArias, C., Valdivieso, R., Núñez, M., Inga, M., Sosa, F., & Acosta, O. (2011). Evaluación del índice de masa corporal y su relación con la hiperglucemia en pacientes diabéticos tipo 2, en Lima Metropolitana, durante el año 2011. In Anales de la Facultad de Medicina, 73, 48. https://doi.org/10.15381/anales.v73i1.2224spa
dcterms.referencesAssociation, A. D. (2015). Diagnosis and classification of diabetes mellitus. Diabetes Care, 37(Supplement 1), S81-S90. https://doi.org/10.2337/dc15-S005eng
dcterms.referencesBallantyne, C. M., Hoogeveen, R. C., Bang, H., Coresh, J., Folsom, A. R., Chambless, L. E., … Boerwinkle, E. (2005). Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident ischemic stroke in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study. Archives of Internal Medicine, 165(21), 2479-2484. https://doi.org/10.1001/archinte.165.21.2479eng
dcterms.referencesBell Castillo, J., George Carrión, W., García Céspedes, M. E., Delgado Bell, E., Bell, G., & de Jesús, M. (2017). Identificación del síndrome metabólico en pacientes con diabetes mellitus e hipertensión arterial. MEDISAN, 21(10), 3038-3045.spa
dcterms.referencesBiben, S., Orkin, S., & Bopp, C. (2016). Prevalence of Metabolic Syndrome Risk Factors in College-Aged Students. In International Journal of Exercise Science: Conference Proceedings, 9, 20.eng
dcterms.referencesBorghi, C., Rosei, E. A., Bardin, T., Dawson, J., Dominiczak, A., Kielstein, J. T., … Mancia, G. (2015). Serum uric acid and the risk of cardiovascular and renal disease. Journal of Hypertension, 33(9), 1729-1741. https://doi.org/10.1097/HJH.0000000000000701eng
dcterms.referencesCabalé Vilariño, M. B., Sánchez Serrano, D., Gutiérrez Carbonell, E., & Flores Sánchez, A. (2011). Prevalencia del síndrome metabólico en pacientes dislipidémicos con antecedentes de revascularización miocárdica. Revista Cubana de Investigaciones Biomédicas, 30(4), 464-470.spa
dcterms.referencesCarvajal, C. C. (2017). Sindrome metabólico: Definiciones, epidemiología, etiología, componentes y tratamiento. Medicina Legal de Costa Rica, 34(1), 175-193.spa
dcterms.referencesCastro, C., & Yaqueline, Y. (2016). Identificación de síndrome metabólico y comparación de las escalas Adult Treatment Panel III The National Cholesterol Education Program (ATP-III) y la Federación Internacional de la Diabetes (FID) en pacientes que acuden a chequeos ejecutivos en el Hospital de los Valles. PUCE.spa
dcterms.referencesCulleton, B. F., Larson, M. G., Kannel, W. B., & Levy, D. (1999). Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study. Annals of Internal Medicine, 131(1), 7-13. https://doi.org/10.7326/0003-4819-131-1-199907060-00003eng
dcterms.referencesDíaz, M. S. (2015). Actualización 2015 del algoritmo ADA/EASD de tratamiento de la hiperglucemia. Diabetes Care, 38(1), 140-149.spa
dcterms.referencesEsser, N., Legrand-Poels, S., Piette, J., Scheen, A. J., & Paquot, N. (2014). Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes. Diabetes Research and Clinical Practice, 105(2), 141-150. https://doi.org/10.1016/j.diabres.2014.04.006eng
dcterms.referencesExpert Panel on Detection, E. (2001). Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Jama, 285(19), 2486. https://doi.org/10.1001/jama.285.19.2486eng
dcterms.referencesFernández, A. G. (2016). Proteína c reactiva, índice de conicidad y factores de riesgo cardiovascular en pacientes con diabetes tipo 2. Universidad Complutense de Madrid.spa
dcterms.referencesGarg, P. K., Norby, F. L., Polfus, L. M., Boerwinkle, E., Gibbs, R. A., Grove, M. L., … Hoogeveen, R. C. (2017). Lipoprotein-associated phospholipase A 2 and risk of incident peripheral arterial disease: Findings from the Atherosclerosis Risk in Communities study (ARIC). Atherosclerosis. https://doi.org/10.1016/j.atherosclerosis.2017.11.007eng
dcterms.referencesGiraldo, N. A. G., Perdomo, A. M. Z., Aristizábal, T. S. T., & Restrepo, A. E. (2017). Síndrome metabólico en un grupo de adultos mayores no institucionalizados según criterios de organismos internacionales. Perspectivas En Nutrición Humana, 18(1), 25-35. http://dx.doi.org/10.17533/udea.penh.v18n1a03eng
dcterms.referencesHan, T. S., Sattar, N., Williams, K., Gonzalez-Villalpando, C., Lean, M. E., & Haffner, S. M. (2002). Prospective study of C-reactive protein in relation to the development of diabetes and metabolic syndrome in the Mexico City Diabetes Study. Diabetes Care, 25(11), 2016–2021. https://doi.org/10.2337/diacare.25.11.2016eng
dcterms.referencesHeiss, G., Snyder, M. L., Teng, Y., Schneiderman, N., Llabre, M. M., Cowie, C., … Gallo, L. (2014). Prevalence of metabolic syndrome among Hispanics/Latinos of diverse background: the Hispanic Community Health Study/Study of Latinos. Diabetes Care, 37(8), 2391-2399. doi:https://doi.org/10.2337/dc13-2505eng
dcterms.referencesIliff, D. (2001). Guidelines for diagnosis and treatment of high cholesterol. JAMA, 286(19), 2400-2401; author reply 2401-2402. https://doi.org/10.1001/jama.286.19.2398eng
dcterms.referencesJiménez, A. E. R., Navarro, J., Islas, M. C., DFranchis, L. J. C., Gómez, J. L., Pichardo, C. N., … López, F. R. E. (2009). Prevalencia del síndrome metabólico en relación con las concentraciones de ácido úrico. Medicina Interna de México, 25(4), 278-284.spa
dcterms.referencesJossa, F., Farinaro, E., Panico, S., Krogh, V., Celentano, E., Galasso, R., … Trevisan, M. (1994). Serum uric acid and hypertension: the Olivetti heart study. Journal of Human Hypertension, 8(9), 677-681.eng
dcterms.referencesKahn, R. (2003). Follow-up report on the diagnosis of diabetes mellitus: the expert committee on the diagnosis and classifications of diabetes mellitus. Diabetes Care, 26(11), 3160. https://doi.org/10.2337/diacare.26.11.3160eng
dcterms.referencesKang, D.-H., & Nakagawa, T. (2005). Uric acid and chronic renal disease: possible implication of hyperuricemia on progression of renal disease. In Seminars in nephrology (Vol. 25, pp. 43-49). https://doi.org/10.1016/j.semnephrol.2004.10.001eng
dcterms.referencesLizarazu Díazgranados, I., Rossi Trespalacios, C., Iglesias Acosta, J., & Mendoza Torres, E. (2010). Síndrome metabólico en trabajadores de la Universidad Libre Seccional Barranquilla, 2009. Salud Uninorte, 26(1), 41-53.spa
dcterms.referencesLópez-Jaramillo, P., Pradilla, L. P., Castillo, V. R., & Lahera, V. (2007). Patología socioeconómica como causa de las diferencias regionales en las prevalencias de síndrome metabólico e hipertensión inducida por el embarazo. Revista Española de Cardiología, 60(2), 168-178. https://doi.org/10.1157/13099463spa
dcterms.referencesManzur, F., de la Ossa, M., Trespalacios, E., Abuabara, Y., & Lujan, M. (2008). Prevalencia de síndrome metabólico en el municipio de Arjona, Colombia. Revista Colombiana de Cardiología, 15(5), 215-222.spa
dcterms.referencesMárquez-Sandoval, F., Bulló, M., Vizmanos, B., Casas-Agustench, P., & Salas-Salvadó, J. (2008). Un patrón de alimentación saludable: la dieta mediterránea tradicional. Antropo, 16, 11-22.spa
dcterms.referencesMatesanz Ruiz, C., Caro de Miguel, C., Campos, F., Gómez de Terreros Caro, J., Ariñez Fernández, C., & Gutiérrez Ortega, C. (2006). Descripción del valor de la proteína C reactiva según dislipemia e historia de tabaquismo. Prevención Del Tabaquismo, 8(1), 18-24.spa
dcterms.referencesMatía Martín, P., Lecumberri Pascual, E., & Calle Pascual, A. L. (2007). Nutrición y síndrome metabólico. Revista Española de Salud Pública, 81(5), 489-505. https://doi.org/10.1590/S1135-57272007000500006spa
dcterms.referencesMelnyk, O. O. (2017). Metabolic syndrome and the risk of chronic kidney disease. KIDNEYS, 6(2), 80-90. https://doi.org/10.22141/2307-1257.6.2.2017.102785eng
dcterms.referencesMody, P., Joshi, P. H., Khera, A., Ayers, C. R., & Rohatgi, A. (2016). Beyond coronary calcification, family history, and C-Reactive protein: cholesterol efflux capacity and cardiovascular risk prediction. Journal of the American College of Cardiology, 67(21), 2480-2487. https://doi.org/10.1016/j.jacc.2016.03.538eng
dcterms.referencesPineda, C. A. (2008). Síndrome metabólico: definición, historia, criterios. Colombia Médica, 39(1), 96-106spa
dcterms.referencesPulido, D. I., Scott, M. L., Barreras, C., Soto, F., Barrios, C., & López, C. M. (2016). Síndrome de ovario poliquístico en mujeres portadoras de síndrome metabólico. Revista Médica Clínica Las Condes, 27(4), 540-544. https://doi.org/10.1016/j.rmclc.2016.07.013spa
dcterms.referencesRidker, P. M., Buring, J. E., Cook, N. R., & Rifai, N. (2003). C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events. Circulation, 107(3), 391-397. https://doi.org/10.1161/01.eng
dcterms.referencesRidker, P. M., Rifai, N., Rose, L., Buring, J. E., & Cook, N. R. (2002). Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. New England Journal of Medicine, 347(20), 1557-1565. https://doi.org/10.1056/NEJMoa021993eng
dcterms.referencesRodríguez, R. G., & García, J. C. (2016). Hábitos de vida saludables en el síndrome metabólico. Medimay, 22(1), 102-106.spa
dcterms.referencesRosales, L., Rivas, E. T., & Troconis, T. J. B. (2017). Estudio de la relación entre las características genéticas asociadas a la leptina y el síndrome metabólico. Caso de un grupo familiar con evidencias de trastorno. Acta Bioclínica, 7(14), 145-168.spa
dcterms.referencesSakkinen, P. A., Wahl, P., Cushman, M., Lewis, M. R., & Tracy, R. P. (2000). Clustering of procoagulation, inflammation, and fibrinolysis variables with metabolic factors in insulin resistance syndrome. American Journal of Epidemiology, 152(10), 897-907. https://doi.org/10.1093/aje/152.10.897eng
dcterms.referencesSoca, P. E. M. (2009). El síndrome metabólico: un alto riesgo para individuos sedentarios. Acimed, 20(2), 0.spa
dcterms.referencesSrikanthan, K., Feyh, A., Visweshwar, H., Shapiro, J. I., & Sodhi, K. (2016). Systematic review of metabolic syndrome biomarkers: a panel for early detection, management, and risk stratification in the West Virginian population. International Journal of Medical Sciences, 13(1), 25. https://doi.org/10.7150/ijms.13800eng
dcterms.referencesTesta, R., Vanhooren, V., Bonfigli, A. R., Boemi, M., Olivieri, F., Ceriello, A., … Bacalini, M. G. (2015). N-glycomic changes in serum proteins in type 2 diabetes mellitus correlate with complications and with metabolic syndrome parameters. PLoS One, 10(3), e0119983. https://doi.org/10.1371/journal.pone.0119983eng
dcterms.referencesTovar, A. P., & Celemin, C. (2016). Menopausia y síndrome metabólico. RFS, 7(1), 69-76. http://dx.doi.org/10.25054/rfs.v7i1.183spa
dcterms.referencesValenzuela, A. (2016). Ácido úrico:?` un nuevo factor contribuyente al desarrollo de obesidad? Revista Chilena de Nutrición, 43(3), 303-307. http://dx.doi.org/10.4067/S0717-75182016000300011spa
dcterms.referencesVirtanen, M., Ferrie, J. E., Akbaraly, T., Tabak, A., Jokela, M., Ebmeier, K. P., … Kivimäki, M. (2017). Metabolic Syndrome and Symptom Resolution in Depression: A 5-Year Follow-Up of Older Adults. J Clin Psychiatry, 78(1), e1-e7. https://doi.org/10.4088/JCP.15m10399eng

Archivos

Bloque original
Mostrando 1 - 1 de 1
Miniatura
Nombre:
Biochemical Markers Present in a Population Susceptible to Suffering.pdf
Tamaño:
178.18 KB
Formato:
Adobe Portable Document Format
Descripción:
Formato Pdf texto completo
Descargar
Bloque de licencias
Mostrando 1 - 1 de 1
No hay miniatura disponible
Nombre:
license.txt
Tamaño:
1.71 KB
Formato:
Item-specific license agreed upon to submission
Descripción:
Descargar

Colecciones

Artículos

Universidad Simón Bolívar: Todos los derechos reservados / Sistema de biblioteca